Navigation Links
AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
Date:5/13/2008

derive varying degrees of benefit from chemotherapy, while patients with less aggressive, low grade (Grade 1) tumors usually derive no benefit. However, approximately 50 percent of all early stage breast cancer patients are diagnosed with an intermediate tumor grade (Grade 2). For these patients the appropriate choice of therapy is unclear. The clinical data published this month demonstrate that Aviara MGI accurately identifies Grade 1 and 3 tumors, and successfully re-classifies intermediate tumor grade (Grade 2) into cases with Grade 1-like or Grade 3-like outcomes.

"The importance of accurate tumor grading cannot be understated," said Dennis C. Sgroi, director of breast pathology at Massachusetts General Hospital and associate professor of pathology at Harvard Medical School, a senior author of the article. "A molecular tool such as MGI that can help separate intermediate-grade tumors into two distinct prognostic groups will go a long way in stratifying risk and improving treatment selection for breast cancer patients."

Researchers combined Aviara MGI and Aviara H/I in order to assess the overall impact of both molecular tumor grade and endocrine therapy benefit on patient outcome. H/I is a well-established biomarker that has been shown to predict both recurrence risk and endocrine benefit in more than 2,000 patients in numerous clinical studies. It assesses the likelihood of a patient to benefit from endocrine therapy by measuring the functionality of the estrogen signaling pathway inside the tumor cell itself. As such, H/I goes beyond conventional estrogen and progesterone receptor (ER/PR) testing. While patients who are ER/PR positive are assumed to benefit from endocrine therapy, the therapy fails in approximately 25 percent of those patients.

"Other gene-signature assays developed for breast cancer provide an improvement over tumor grade as a measure of breast cancer aggressiveness and likely benefit from chemotherapy. These different pr
'/>"/>

SOURCE AviaraDx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
2. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
3. FDA Confirms Seizure of Eyelash Product Was Not Prompted by Reports of Adverse Effects
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
6. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
7. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
8. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
9. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
10. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
11. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... BOSTON , December 15, 2014 ... and development company, is pleased to announce the grant ... States relating to its GPCR-focused drug discovery ... significantly strengthens the global patent estate covering Heptares, technologies ... The suite of patents recently granted by the US ...
(Date:12/13/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ) ... Injection Devices to 2020" report to their ... As new drugs become available for ... conditions, drug developers have increasingly pursued packaging and ... increase the efficiency and reliability with which the ...
(Date:12/13/2014)... , Dec. 12, 2014  Radiologists can ... to images, to their referring physicians, electronic health ... using carefully selected technology.  That ... Data Systems Corporation (ADS) at the recent Radiology ... The transmitting of radiology reports in this manner ...
Breaking Medicine Technology:Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3
... Esperion Therapeutics, a privately held biotechnology company ... cardiovascular and metabolic diseases, today announced that it ... ETC-1002, the company,s lead product candidate. ETC-1002 is ... preclinical and clinical activity as a metabolic regulator ...
... 6, 2011 ChemoCentryx, Inc., today announced that Thomas ... present at J.P. Morgan,s 29 th Annual Healthcare ... Pacific at the Westin St. Francis Hotel in San ... ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused ...
Cached Medicine Technology:Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002 2ChemoCentryx to Present at the 29th Annual J.P. Morgan Healthcare Conference 2
(Date:12/15/2014)... SIMpalm, a leading mobile app development ... for its client, which allows users to keep track ... in finding the right wine. At the center ... sensory, chemistry and wine information. All this information is ... Those wines that are close counterparts to one another ...
(Date:12/15/2014)... Boston, MA (PRWEB) December 15, 2014 ... health management solutions, announced today that it has ... for Quality Assurance (NCQA) for its Disease Management ... obstructive pulmonary disease (COPD), coronary heart disease and ... accreditation from NCQA for Health Dialog’s Disease Management ...
(Date:12/15/2014)... 14, 2014 (HealthDay News) -- Expert pilots process visual ... why they make better decisions during landings, a new ... difficult techniques for pilots to master, and 36 percent ... crashes occur during final approach and landing. Researchers ... 12 moderately experienced pilots while they were at the ...
(Date:12/15/2014)... CT (PRWEB) December 15, 2014 Kathy ... the prestigious Women World Awards in the category of ... a gold award for her weekly career blog ... practical advice to help professionals elevate their talent and ... Her blog, named after her book Networking Ahead for ...
(Date:12/15/2014)... In support of high-quality independent ... restrictive state laws that may have unintended consequences ... area of public health policy. , The position ... of Independent Review, contends that state legislation that ... review determinations can result in subpar outcomes for ...
Breaking Medicine News(10 mins):Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... University of Pennsylvania School of Medicine discovered that proteins ... exposed to the tau protein, which plays an important ... proteins transport cellular cargo towards opposite ends of tracks ... acts like a speed bump to regulate protein traffic, ...
... CHICAGO, Jan. 17 Bankers Life and Casualty Company ... Health and Human,Services in implementing a study with senior ... over age 65 fall each year, and falls,are a ... cause of nonfatal,injuries," said Scott Perry, president of Bankers, ...
... answer may depend on outcomes of ongoing clinical trials, expert ... reports that statins might slow or prevent Alzheimer,s disease, a ... While some animal studies have suggested this possibility, whether the ... said. , "We didn,t find a relation between statin ...
... researchers say , , THURSDAY, Jan. 17 (HealthDay News) -- By ... say they,re gaining new insight into how some children are ... report in a new study that both twins -- one ... that mutated and became precancerous. In one of the twins, ...
... ... young children., BERKELEY SPRINGS, W.Va., Jan. 17 The US ... is too risky,for babies and toddlers on Thursday according to recent ... parents of the serious and,potentially life threatening side effects of cold ...
... for Life-Threatening, Genetic,Disease, WASHINGTON, Jan. 17 All ... beginning today. Montana is the,37th state in the country, ... states that support routine CF screening at birth., ... states dedicated,to supporting newborn screening for cystic fibrosis," said ...
Cached Medicine News:Health News:Alzheimer's molecule is a smart speed bump on the nerve-cell transport highway 2Health News:Bankers Life and Casualty Company Joins LifePlans, Inc. and the Department of Health and Human Services to Launch Fall Prevention Program Study For America's Seniors 2Health News:Latest Study Says Statins Don't Slow Alzheimer's 2Health News:Study Gets Closer to Origins of Leukemia 2Health News:FDA to Declare Cold Medicines Too Risky, Homeopathy Offers a Safe Alternative 2Health News:Montana Passes Newborn Screening Law for Cystic Fibrosis 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: